We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

ATM A2067D - Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene ATM
Variant A2067D
Impact List missense
Protein Effect loss of function
Gene Variant Descriptions ATM A2067D lies within the FAT domain of the Atm protein (UniProt.org). A2067D confers a loss of function to Atm, resulting in reduced Atm protein expression and decreased Atm kinase activity in cell culture (PMID: 25077176).
Associated Drug Resistance
Category Variants Paths

ATM mutant ATM inact mut ATM A2067D

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000051.4
gDNA chr11:g.108317374C>A
cDNA c.6200C>A
Protein p.A2067D
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_011542840.3 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017790 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542844.4 chr11:g.108329175C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
NM_000051 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_005271562 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_006718843.5 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_006718843 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_047426975.1 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_005271562.5 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
NM_000051.3 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_005271562.6 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
NM_001351834.2 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_006718843.4 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_005271561 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542840 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017789.2 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542840.4 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017791 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542843 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542843.3 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_047426976.1 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017791.1 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
NM_000051.4 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017790.3 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
NM_001351834.1 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017789 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_017017790.2 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542844.3 chr11:g.108329175C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542844 chr11:g.108329175C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38
XM_011542843.2 chr11:g.108317374C>A c.6200C>A p.A2067D RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
ATM A2067D prostate cancer sensitive Olaparib FDA approved - On Companion Diagnostic Actionable In a Phase III trial (PROfound) that supported FDA approval, Lynparza (olaparib) improved progression-free survival (7.4 vs 3.6 mo, HR 0.34, p<0.001), objective response rate (33% vs 2%, OR 20.86, p<0.001), and median overall survival (18.5 vs 15.1 mo, HR 0.64, p=0.02) over control in metastatic prostate cancer patients harboring inactivating BRCA/ATM mutations as detected by approved assays, including ATM A2067D, HR was 1.04 in ATM-mutant group (PMID: 32343890; NCT02987543). detail... detail... 32343890